Skip to content

Is a plaque-identifying toothpaste useful for reducing plaque in children (age 12-16 years) treated with fixed orthodontic appliances?

The effect of a plaque-identifying toothpaste on the amount of plaque in 12-16-year-old patients treated with fixed orthodontic appliances: a randomized, double-blind, controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN53131830
Enrollment
80
Registered
2022-05-03
Start date
2021-10-25
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of plaque accumulation around brackets in patients with a malocclusion undergoing orthodontic fixed appliance treatment. Oral Health

Interventions

A prospective, randomised, double-blind, placebo-controlled trial will be conducted at the orthodontic department of the University Medical Center Groningen, the Netherlands. The G*Power program (G*Po

Sponsors

University Medical Center Groningen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are treated in the Orthodontics department of the University Medical Center Groningen (UMCG) 2. Age category from 12 to 16 years 3. Under treatment with fixed orthodontic appliances in both jaws for at least three months 4. Twelve permanent anterior elements, namely from cuspid to cuspid, present 5. No syndromic or other craniofacial anomalies

Exclusion criteria

Exclusion criteria: 1. Participants from the same family 2. Allergy to one of the components of the toothpastes used 3. Intervention or appointment with a dental professional (prevention assistant, dental hygienist, dentist or specialist) during the study

Design outcomes

Primary

MeasureTime frame
Plaque is measured with Quantitative Light Fluorescence as a surface measurement on intra-oral photographs of the buccal tooth surfaces in the anterior region (lower and upper cuspid to cuspid). At baseline (T0) and at 6 weeks after baseline (Tl, end of study).

Secondary

MeasureTime frame
User experience questionnaire at 6 weeks after baseline

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 27, 2026